Erlotinib NewsLatest News On Erlotinib Type II Cryoglobulinemic Vasculitis Signals Poor Prognosis in Sjögren Disease8/6/2025 2:31 PM Disease Monitoring: Key to Better Leukemia Outcomes?8/4/2025 5:57 AM Pemphigoid or Psoriasis? 65-Year-Old’s Remote Diagnosis Race7/30/2025 1:24 AM New Antibody-Drug Conjugates Expand Treatment Options for HER2+ and MET+ Lung Cancer7/29/2025 9:37 AM Rituximab No Better Than Standard Therapy for Remission of Eosinophilic Granulomatosis With Polyangiitis7/29/2025 5:25 AM DLBCL Debate: Is Pola-R-CHP a Suitable Standard for All?7/8/2025 12:24 PM Emerging Themes in GI Oncology from ASCO 20257/1/2025 4:44 PM Sclerosing Mesenteritis: What GIs Need to Know About This Rare Disease6/27/2025 7:31 AM Which First-line Tx Combo Is Best for HER2+ Breast Cancer?6/6/2025 8:43 AM Ph+ALL: Post-Induction, Ponatinib Yields Molecular Response5/31/2025 2:45 PM
